Well, the federal government released data Sept. 24 showing that the obesity epidemic, one of the most dire public health crises, might have stopped worsening. And there is reason to imagine the ...

Schweikert told the Washington Examiner that the U.S. has tools at its disposal to address the obesity crisis and that failing to address the matter is “immoral.” “In the next decade ...

The data showed that kids who don’t see their BMI decline between ages 1 and 6 have a greater risk of obesity. This risk was ...

Not all children grow the same way. A new study from the Environmental influences on Child Health Outcomes (ECHO) Program ...

Emmanuela Gakidou, lead author, Professor from the Institute for Health Metrics and Evaluation (IHME), University of Washington, USA "Overweight and obesity can trigger serious health conditions ...

As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

Editor’s note: Watch “Dr. Sanjay Gupta Reports: Is Ozempic Right For You?” at 8 p.m. Sunday, November 17, on CNN. In a little over two decades, almost 260 million people in the United States ...

Recently, an international commission proposed a revised definition of obesity that focuses on how ... and adjunct associate professor at George Washington University. She previously was Baltimore ...

The highly anticipated White House report on childhood diseases, titled "Make Our Children Healthy Again: Assessment," was ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.